Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung transplantation

P M McFadden1, W B Emory

  • 1Department of Surgery, Ochsner Clinic, New Orleans, Louisiana, USA.

The Surgical Clinics of North America
|January 19, 1999
PubMed
Summary
This summary is machine-generated.

Lung transplant survival is improving, but infection and bronchiolitis obliterans remain major challenges. Controlling these issues is key to better long-term outcomes for lung transplant recipients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in lung transplantation.

Ochsner journal·2011
Same author

Issue editor.

Ochsner journal·2011
Same author

Minimally invasive thoracic surgery.

Ochsner journal·2011
Same author

Clarithromycin for safe and cost-effective reduction of cyclosporine doses in lung allograft recipients.

Southern medical journal·2000
Same author

Assessment of thoracoscopic sympathectomy by infrared thermal imaging.

The Annals of thoracic surgery·2000
Same author

Long-term outcome of cardiac allograft vasculopathy treated by transmyocardial laser revascularization: early rewards, late losses.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2000

Area of Science:

  • Medicine
  • Transplantation immunology
  • Pulmonology

Background:

  • Lung transplantation survival rates are improving but still lag behind other solid organ transplants.
  • The lung allograft's environmental exposure makes it highly susceptible to infection, a primary cause of morbidity and mortality.
  • Bronchiolitis obliterans syndrome (BOS) is a leading cause of late graft failure and is currently untreatable.

Purpose of the Study:

  • To review the current status of lung transplantation outcomes.
  • To identify the major challenges impacting long-term survival after lung transplantation.
  • To highlight the importance of managing infection and rejection for improved patient outcomes.

Main Methods:

  • Review of current literature on lung transplantation outcomes.

Related Experiment Videos

  • Analysis of factors contributing to early and late morbidity and mortality.
  • Discussion of the pathophysiology of infection and bronchiolitis obliterans syndrome.

    • Main Results:

    • Lung transplant survival rates show improvement.
    • Infection is the predominant cause of early and late complications.
    • Bronchiolitis obliterans syndrome (BOS) is the second leading cause of late morbidity and mortality.

    Conclusions:

    • Effective management of infections is crucial for improving lung transplant outcomes.
    • Addressing subclinical rejection and preventing infection are essential for enhancing intermediate and long-term survival.
    • Further research into the multifactorial causes of BOS is needed to develop effective treatments.